Concepedia

Martin D. Phillips

MD

Statistics

Publications

12

Citations

1.2K

H-Index

12

Active since

1993

Affiliations

Morphotek (United States)(Current)

The University of Texas MD Anderson Cancer Center

Sidney Kimmel Cancer Center

Texas Medical Center

Martin D. Phillips is an author at Morphotek (United States) specializing in medicine, hemostasis, and oncology.

Publications per year

1993–2013

12

Publications

12

Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers

Raffit Hassan, Steven J. Cohen, Martin D. Phillips et al. · Clinical Cancer Research · 2010 · 200 citations · Full text

, , +17

Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.

Raffit Hassan, Wolfgang Ebel, Eric Routhier et al. · PubMed · 2007 · 189 citations · Full text

, , +11

Farletuzumab, a Humanized Monoclonal Antibody against Folate Receptor α, in Epithelial Ovarian Cancer: a Phase I Study

Jason Konner, Katherine M. Bell‐McGuinn, Paul Sabbatini et al. · Clinical Cancer Research · 2010 · 158 citations

, , +16

Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer

Deborah K. Armstrong, Allen J. White, Susan C. Weil et al. · Gynecologic Oncology · 2013 · 151 citations

, , +16

Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha.

Wolfgang Ebel, Eric Routhier, Brian Foley et al. · PubMed · 2007 · 137 citations · Full text

, , +17

1–5 of 12